Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Down 8.6% in December

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) saw a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 1,490,000 shares, a decrease of 8.6% from the December 15th total of 1,630,000 shares. Based on an average daily trading volume, of 303,600 shares, the days-to-cover ratio is currently 4.9 days. Approximately 4.2% of the shares of the company are short sold.

Institutional Trading of Astrana Health

Institutional investors and hedge funds have recently bought and sold shares of the company. GAMMA Investing LLC purchased a new position in shares of Astrana Health during the 3rd quarter valued at $34,000. Nisa Investment Advisors LLC purchased a new position in Astrana Health during the third quarter worth about $35,000. KBC Group NV bought a new position in Astrana Health in the 3rd quarter worth about $70,000. Quarry LP purchased a new stake in shares of Astrana Health in the 3rd quarter valued at about $77,000. Finally, Quest Partners LLC bought a new stake in shares of Astrana Health during the 3rd quarter valued at about $133,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Stock Performance

Shares of NASDAQ:ASTH traded up $1.81 during midday trading on Friday, reaching $35.17. 719,476 shares of the company traded hands, compared to its average volume of 289,002. The firm's fifty day moving average price is $37.26 and its two-hundred day moving average price is $46.72. The firm has a market capitalization of $1.98 billion, a price-to-earnings ratio of 27.05, a price-to-earnings-growth ratio of 1.12 and a beta of 1.20. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health has a 12 month low of $29.08 and a 12 month high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $478.71 million for the quarter, compared to analysts' expectations of $462.01 million. During the same period in the prior year, the business posted $0.47 earnings per share. On average, equities analysts expect that Astrana Health will post 1.16 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently issued reports on ASTH shares. KeyCorp initiated coverage on shares of Astrana Health in a report on Friday, October 11th. They set a "sector weight" rating for the company. BTIG Research lifted their price target on shares of Astrana Health from $60.00 to $70.00 and gave the stock a "buy" rating in a report on Thursday, October 3rd. Truist Financial reduced their price objective on Astrana Health from $59.00 to $50.00 and set a "buy" rating for the company in a report on Monday, January 13th. Macquarie upgraded Astrana Health to a "hold" rating in a research note on Monday, December 16th. Finally, Robert W. Baird upped their price target on Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a research report on Wednesday, November 13th. Two research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Astrana Health presently has an average rating of "Moderate Buy" and an average price target of $63.67.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.